A prospective comparative study to evaluate the effect of Myo-inositol plus diet vs diet alone in patients with gestational diabetes mellitus
1 Bharat School of pharmacy, Mangalpally, Ibrahimpatnam, Hyderabad-501510, India.
2Department of obstetrics and gynaecology, Durgabai Deshmukh Hospital and Research Centre, Vidyanagar, Hyderabad, India.
Research Article
GSC Biological and Pharmaceutical Sciences, 2021, 14(03), 197-201.
Article DOI: 10.30574/gscbps.2021.14.3.0076
Publication history:
Received on 09 January 2021; revised on 13 March 2021; accepted on 16 March 2021
Abstract:
Aim: The aim of this study was to compare the effect of Myo-inositol plus diet and diet alone in patients with gestational diabetes mellitus.
Materials and methods: A Randomized Prospective study was carried out in Gestational Diabetes Mellitus patients to evaluate the efficacy of Myoinositol+diet vs Diet alone in the department of Gynaecology, Durgabhai Deshmukh Hospital, a 300 bedded multispecialty hospital from September 2018-April 2019.OGTT test was conducted to measure blood glucose levels.
Results: Among the total number of patients (60), Myoinositol + diet is given in 50% and diet is given in 50% of the patients. Among 30 patients on diet, 19 patients couldn’t control rising blood glucose levels and were prescribed insulin for reduction of blood glucose levels. Among 30 patients on myoinositol+ diet, 4 patients couldn’t control 1 hr blood glucose levels and were prescribed insulin to control blood glucose levels.
Conclusion: This study showed that Myoinositol + diet is effective than only diet with respect to decrease in blood glucose levels and safety among patients with Gestational Diabetes Mellitus. Therefore, we conclude that myoinositol + diet is safe and effective in reducing fasting and 2hr blood glucose levels.
Keywords:
Gestational diabetes mellitus; Myoinositol; OGTT test; Diet; Insulin
Full text article in PDF:
Copyright information:
Copyright © 2021 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
